Vol. 274, Issue 1, F1-F9, January 1998
INVITED REVIEW
Molecular structure and assembly of the tight junction
Bradley M.
Denker and
Sanjay K.
Nigam
Renal Division, Brigham and Women's Hospital and Harvard Medical
School, Boston, Massachusetts 02115
 |
ABSTRACT |
Polarized epithelial
cells separate two extremely different cellular milieus. The tight
junction (TJ) is the most apical component of the junctional complex
and serves as the permeability barrier between these environments. The
tight junctional complex appears to be a dynamic and regulated
structure. Some of its protein components have been identified and
include the transmembrane protein occludin. Nontransmembrane proteins
on the cytosolic leaflet including ZO-1, ZO-2, cingulin, 7H6, and
several unidentified phosphoproteins are also believed to be part of
the TJ. Interactions of some of these proteins with the actin
cytoskeleton are a major determinant of TJ structure and may also play
a role in the regulation of TJ assembly. Recent progress using the
"calcium switch" and the "ATP depletion-repletion" model of
TJ formation offers new insight regarding how these structures
form. TJ biogenesis appears to be regulated, in part, by
classic signal transduction pathways involving heterotrimeric G
proteins, release of intracellular Ca2+, and activation of protein
kinase C. Although many of the details of the signaling
pathways have yet to be defined, these observations may provide insight
into how TJs form during tubular development. Furthermore, it may be
possible to suggest potential therapeutic targets for intervention in a
variety of diseases (e.g., ischemia, toxic injury to the kidney and
other epithelial tissue) where TJ integrity has been compromised and
reassembly is required.
epithelia; occludin; kidney; signaling; G proteins; protein kinase
C
 |
INTRODUCTION |
POLARIZED EPITHELIAL CELLS function, in part, to
provide a permeability barrier between two very different environments
and to enable vectorial transport across the cellular layer. Highly specialized cellular components have evolved that allow epithelia to
form an impermeant barrier and segregate cell surface membrane proteins
and lipids into the apical and basolateral membrane domains. The
junctional complex of polarized epithelia is a highly developed structure that was first appreciated in detail by electron microscopy in the 1960s. The junctional complex includes several well-defined structures including gap junctions, desmosomes, adherens junctions, and
the tight junction (TJ) (see Fig. 1). Gap junctions mediate communication between cells by allowing small molecules to pass from
cytoplasm to cytoplasm of neighboring cells, thereby metabolically and
electrically coupling them together (reviewed in Ref. 33). Desmosomes
are "buttonlike" points of intercellular contact that rivet cells
together and provide anchoring sites for intermediate filaments (Fig.
1) (reviewed in Ref. 23). Adherens junctions form a continuous belt
(the adhesion belt) and function to hold neighboring cells together
through a family of Ca2+-dependent
cell-cell adhesion molecules (cadherins) that are linked to actin and
myosin filaments (Fig. 1) (reviewed in
Refs. 26, 59). The TJ is the most apical component of the junctional
complex and functions as the "fence" separating apical from
basolateral domains, and is the major paracellular barrier. The protein
components of the TJ and the basis for regulation of paracellular
permeability have recently been reviewed (2). This review will focus
upon recent advances in our understanding of how TJs are formed. The assembly of TJs in polarized epithelia is a critical event during tubular and ductal development and during recovery from ischemic or
toxic injury (e.g., intestine and kidney). Over the past several years,
work from a number of laboratories has helped to identify important
proteins within the TJ and to define key events in TJ formation.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Epithelial cell junctional complex. Tripartite junctional complex
contains the tight junction (TJ), adherens junctions, and desmosomes.
The most apical component of the junctional complex is the TJ, which
functions as a permeability barrier and separates apical from
basolateral membrane domains. Occludin is the only known protein of the
TJ with domains in the paracellular space. The adherens junction
anchors cells together through the
Ca2+-dependent cell adhesion
molecules, E-cadherins. The adherens junction forms a continuous belt
linked to actin and myosin filaments. Desmosomes are buttonlike
structures that hold cells together and provide anchoring sites for
intermediate filaments. An additional type of cellular junction, gap
junctions, allows small molecules to pass from one cell into another
(not shown).
|
|
 |
PROTEINS OF THE TIGHT JUNCTION |
Before reviewing events important for the assembly of TJs, it will be
useful to summarize the current understanding of proteins known to be
associated with the TJ. Some of the major proteins of the TJ are
schematized in Fig. 2, and the known TJ
proteins are summarized and listed in Table
1.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
Schematic representation of occludin and proteins that coprecipitate
with ZO-1. Occludin has two extracellular loops that may interact with
other molecules in the paracellular space. The COOH terminus (C) of
occludin interacts with ZO-1, and immunoprecipitates of ZO-1
coprecipitate ZO-2 and several unidentified phosphoproteins (see text
for details) including p130. In the ATP-depletion model, fodrin also
tightly associates with ZO-1. There are many other molecules that have
been described in the TJ, and these are summarized in Table 1 and in
the text. N, NH2
terminus.
|
|
Occludin. The points of contact
between cells visualized by electron microscopy reveal
rows of intramembrane particles that form long branching fibrils
circumscribing the cell (16). These fibrils are thought to represent
linear polymers of transmembrane proteins that associate with similar
particles in neighboring cells. The paracellular permeability between
epithelial cells behaves as if the barrier contains pores or channels
with a distinct preference for cations and molecules between 8 and 18 Å (9, 16). Recently, a transmembrane protein that may provide
the basis of these structures has been identified, and it is called occludin. Monoclonal antibodies to junctional membranes from chicken liver were used to identify a 65-kDa protein that is exclusively localized by immunoelectron microscopy at the TJ of many different cell
types (21). Mammalian homologs of chicken occludin have now been
identified and are ~90% identical to each other but only 50%
identical to chicken (3). The topology of occludin predicts the
NH2 and COOH termini to be in the
cytoplasm with two extracellular loops projecting into the paracellular
space (Fig. 2). The loops within the paracellular space may interact
with loops originating from occludin in the neighboring cell or
unidentified molecules to promote interaction and "sealing" of
the paracellular space. Occludin migrates on sodium dodecyl
sulfate-polyacrylamide gel electrophoresis as a series of bands between
62 and 82 kDa, depending upon the degree of phosphorylation.
Phosphorylation occurs on serine or threonine residues, and the degree
of phosphorylation may affect localization in the cell. The less
phosphorylated forms (smaller sizes) are found in the basolateral
membrane, cytosol, and TJ, whereas the more heavily phosphorylated form
(larger size) is concentrated exclusively in the TJ (44). Recent
evidence confirms the notion that occludin is a functional component of the paracellular pathway. Expressing chicken occludin in baculovirus caused multilamellar structures to accumulate in the cytoplasm that
resembled TJs (20). Induction of chick occludin in MDCK cells caused an
increase in transepithelial resistance (TER) and an
increase in the number of TJ strands (35). Interestingly, as the
duration of exposure to the inducing agent
[isopropyl-
-D-thiogalactopyranoside (IPTG)] was increased, there was not only an increase in TER but also in mannitol flux. This "paradox" has been seen in other
studies (7) and is thought to reflect different characteristics of the
paracellular pathway. Treatment of A6 cells with peptides to the two
extracellular loops indicates that loop two has a direct role in
forming the paracellular permeability barrier. Cells treated with a
peptide to the occludin extracellular loop
2, but not loop 1,
reduced transepithelial resistance and increased paracellular flux of
molecules up to 40 kDa. This occurred by reducing the amount of
occludin at the TJ without obviously affecting cell viability,
morphology, or other TJ protein levels (58). These results raise the
possibility that occludin can be independently regulated without
affecting other TJ proteins and that at least one of the extracellular
loops is important to paracellular permeability. The COOH-terminal
cytoplasmic domain of occludin is important for interaction with
another TJ protein, ZO-1, as COOH-terminal deletions of ~150 amino
acids prevented association with ZO-1 (22). Association with ZO-1 may
also be important for localization of occludin to the TJ: in one study,
COOH-terminal deletions of occludin failed to localize in the TJ (22),
but in another study, a large COOH-terminal deletion (~250 amino
acid) of occludin was found in the TJ, although in a discontinuous
pattern (7). Similar to cells overexpressing occludin (35), cells
transfected with COOH-terminally deleted occludin paradoxically
increased both TER and paracellular flux while disturbing the
separation of lipids into apical and basolateral membrane domains (7).
The finding of increased TER and paracellular flux in cells expressing
COOH-terminally deleted occludin has been proposed to occur through
different effects of the mutant occludin on the sealing (electrical)
features of the TJ and the flux characteristics of potential pores or
channels in the TJ (7). The reasons for the different localization of COOH-terminally truncated occludin in the two studies are not clear but
may result from differences in the extent of the COOH-terminal deletions and different systems of study.
ZO-1/ZO-2. Of several cytoplasmic
proteins associated with the TJ, ZO-1 and ZO-2 (zona occludens 1 and 2)
are the best characterized (Fig. 2). ZO-1 was identified in 1986 using
specific monoclonal antibodies raised to a mouse liver-TJ fraction (48,
49). ZO-1 is found in TJs and in filtration slits of
glomerular epithelial cells and in some cadherins junctions such as the
intercalated discs of cardiac myocytes (31). ZO-2 appears to more
restricted to TJs. TJs among various cell types can differ
significantly, and multiple isoforms of ZO-1 and ZO-2 may contribute to
these differences (2, 8). ZO-1 and ZO-2 interact with each other (25),
and ZO-1 binds to the COOH-terminal tail of occludin (Fig. 2) (22).
Both ZO-1 and ZO-2 belong to the membrane-associated guanylate kinase
(MAGUK) family of proteins (reviewed in Ref. 1). Members of this
recently described family are often found at sites of cell-cell contact
and may function to couple extracellular signaling pathways with the
cytoskeleton. MAGUK family members share several conserved motifs
including an SH3 domain, guanylate kinase domain, and PDZ domain(s).
The PDZ domains are named for the three proteins in which the domain
was first recognized (i.e., the initial letters of PSD-95, Dlg, and
ZO-1). PSD-95 is a protein of the postsynaptic density, and Dlg is the
product of the Drosophila lethal(1)discs-large-1 tumor
suppressor gene that is located on the cytoplasmic surface of septate
junctions. The SH3 domain is likely to be important for interaction
with other signaling molecules or the cytoskeleton. The guanylate
kinase domains are similar to the ATP-dependent enzyme that converts
GMP to GDP, but there is significant variability of this domain among
family members. PDZ domains appear to interact with the COOH-terminal
cytoplasmic tail of transmembrane proteins, and this may be the
mechanism of ZO-1-occludin interactions. Recently, the binding
specificity for several PDZ containing proteins was determined (46),
and it is likely that internal amino acid sequences can also bind to
PDZ domains. Some PDZ proteins such as p55 in red blood cells and hDlg
(human homolog of Drosophila dlg)
bind directly to the actin binding protein 4.1. In contrast, other PDZ
proteins, such as Lin-2 in Caenorhabditis
elegans, are not associated with the membrane but
appear to be important for signaling vulval cell induction (reviewed in
Refs. 1 and 34).
Cingulin, 7H6, and others. Several
other proteins have been localized to the TJ including cingulin (15),
7H6 (62), rab 13 (57), G
i-2
(17, 18), and protein kinase C (PKC) (19, 50). Cingulin is a 140-kDa
protein described in 1988 (14) and is located in the junctional regions
of epithelial cells from a variety of epithelial tissues (reviewed in
Ref. 11). Cingulin appears to be two peptides intertwined as a
"coiled coil" and is localized in close proximity to
the vinculin-rich cytoskeletal belt associated with adherens junctions
of chick embryonic kidney cells and in the TJ of chicken intestine
(15). 7H6 (155 kDa) is a protein within the TJ of hepatocytes and
epithelial cells that is recognized by a specific monoclonal antibody
that was generated to a bile canaliculus-rich membrane fraction from
liver (62). 7H6 has been described in endothelial cells, and in both endothelial and epithelial cells it may function to regulate
paracellular permeability (45, 61). In addition, immunoprecipitations
from 32P-labeled MDCK cells have
identified a series of phosphoproteins. ZO-1 coprecipitates ZO-2 and
labeled proteins of 330, 130, and 65 kDa (Fig. 2; Table 1) (6, 50, 61).
Immunoprecipitations of cingulin coprecipitate a band of ~200 kDa
that is not ZO-1 (13). The ~130-kDa proteins appears to be homologous
to the ZO-1/ZO-2 family (B. Stevenson, personal communication). The
small G proteins, Rab 13 and Rab3B (57, 60) in addition to the
heterotrimeric G proteins,
G
i-2, and the recently
described G
family member, G
12 (17-19), have been
identified in this region and may participate in the maintenance
and/or regulation of TJ assembly. The tyrosine protooncogene
c-Yes and the Src substrate p120 are also found near the TJ (41, 54).
Recently, a novel protein (Symplekin) has been described
on the cytoplasmic side of the TJ (32). This 127-kDa protein is not
found in the junctions of endothelial cells but is widely expressed
among many other cell types. Interestingly, Symplekin appears to be
predominantly located in the nucleoplasm and is recruited
to the TJ in those cells forming TJs. A nuclear localization has also
been described for ZO-1 in subconfluent cells, but the implications for
the nuclear localization of ZO-1 in TJ assembly are not clear (24).
 |
MECHANISMS OF TIGHT JUNCTION ASSEMBLY |
Studies with cultured cell monolayers and intact tissues have been able
to identify some of the second messenger and signaling pathways
important for the assembly of TJs. To date, multiple signal
transduction pathways have been implicated in TJ biogenesis including
kinases (6, 12, 36, 38), Ca2+ (37,
51, 52), G proteins (5, 18), calmodulin, adenosine 3',5'-cyclic monophosphate (cAMP), and phospholipase C (5). Some of these signaling molecules are schematized in Fig. 4. Unraveling these pathways will be a major challenge in the next several years and
is complicated by the observation that different epithelial cells may
assemble and regulate TJs differently. There are likely to be some
parallels between epithelial and endothelial cell TJ assembly, but
epithelial cells are more diverse and will likely utilize some unique
mechanisms. MDCK cells (epithelial cells derived from dog kidney) have
been extensively utilized for the study of junction formation (reviewed
in Ref. 10). Two different models of TJ assembly in epithelial cells
have been used: the Ca2+ switch
model and the ATP depletion-repletion model. The mechanisms of
junctional assembly appear to be different in each of these models
(53). The Ca2+ switch model has
been widely utilized for studies of TJ assembly and is based the
observation that MDCK cells plated at confluence establish TJs in
12-15 h through a process requiring protein synthesis, formation
of an actin filament ring in close contact with the lateral membrane,
calmodulin, and a Ca2+-dependent
exocytic fusion of TJ proteins. Monolayers incubated in the absence of
Ca2+ (low calcium,
LC) lack cell-cell contact, intercellular junctions, and
apical-basolateral polarization of lipids and protein. The formation of
junctions can be followed by measurement of TER, an indicator of
monolayer integrity (Fig. 3). Raising
extracellular Ca2+ (normal
calcium, NC; Ca2+ switch) triggers
a series of molecular events that restores TJs, polarity, and TER (Fig.
3).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 3.
Comparison of the Ca2+ switch and
ATP depletion-repletion models of TJ biogenesis. In both models, MDCK
cells are plated at confluence on filters. Cells maintain an epithelial
phenotype with apical and basolateral membranes domains that are
defined by the TJ (hatched circles). Adherens belt is depicted as
broken lines through the middle of the cell. When placed in low
Ca2+ (µM), the cells become
rounded, lose apical and basolateral domains, and allow unregulated
flux across the monolayer (followed by transepithelial resistance, a
reliable indicator of TJ integrity). In low
Ca2+ (LC, µM), transepithelial
resistance (TER) is near zero, and ZO-1 is found in intracellular
granules (hatched circles) that also contain catenins. Upon restoring
normal Ca2+ (NC, mM;
Ca2+ switch), ZO-1 translocates to
the lateral membrane and becomes more tightly associated with actin
cytoskeleton. In contrast, during ATP depletion, TER also falls to near
zero, but ZO-1 remains in the subapical lateral membrane and becomes
more tightly associated with fodrin (depicted as 3 connected ovals
along the lateral membrane) and other cytoskeletal proteins. With ATP
repletion, ZO-1 interactions with cytoskeletal proteins normalize, and
TER returns toward baseline.
|
|
Reestablishing the architecture of the actin cytoskeleton appears to be
critical for the biogenesis of TJs. Most of the actin is positioned
under the apical junctional complex where myosin II and several actin
binding proteins including
-actinin, vinculin, and radixin have been
identified (Fig. 4). ATP-dependent
contraction of the apical actin cytoskeleton of enterocytes was
recognized in the mid 1970s (42), and it is well established that
actin-disrupting drugs, such as cytochalasin, also perturb the
paracellular barrier (47). Drugs that perturb the actin cytoskeleton
are likely to disrupt the TJ through effects on actin originating on
the perijunctional ring that projects onto the cytoplasmic surface of
the TJ (29). Myosin movement along actin filaments is
regulated by ATP and phosphorylation of the regulatory light chain by
Ca2+-calmodulin-activated
myosin light-chain kinase. In several systems, increases in
intracellular Ca2+ can affect
phosphorylation of myosin regulatory light chain contraction of
perijunctional actin and cause increased paracellular permeability (55). Recent advances in understanding the
signaling pathways important for cytoskeletal rearrangements during
cell migration may have relevance for the biogenesis and/or
maintenance of TJs. For example, the small GTP binding protein Rho
regulates actin filament organization, and in polarized epithelial
cells Rho also regulates organization and permeability of the TJ (Fig.
4) (39). Other proteins such as Rac and focal adhesion kinase (FAK)
play a role in membrane ruffling and establishment of focal adhesion (reviewed in Ref. 28), although it is unknown whether these molecules
also participate in regulation of TJs.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Potential interaction of signaling molecules in TJ biogenesis. Fodrin
and the subapical cytoskeleton are shown under the apical membrane as a
circle and in the midst of cross-hatched lines. TJ complex is below
actin/fodrin and is depicted as a complex of occludin (transmembrane
protein) with phosphoproteins (ZO-1, ZO-2, and P-130), which can
potentially be phosphorylated on serine and tyrosine residues. Other
possible signaling molecules including G subunits, small GTPases
(Rab/Rho), tyrosine kinases (Tyr-kinases) and potential tyrosine
phosphates (?TP) are depicted in the vicinity of the TJ complex.
Stimulation of phospholipase C and perhaps other effectors leads to
formation of inositol trisphosphate
(IP3) and diacylglycerol (DAG).
IP3 releases intracellular calcium
from the endoplasmic reticulum (ER) which, in conjunction with DAG,
activates protein kinase C (PKC). PKC translocates to the TJ, but it is
not known whether the phosphorylation of TJ proteins occurs via PKC or
unidentified kinase(s). There may also be calcium-dependent and
-independent isoforms in the TJ. The receptor(s) that initiates these
events is not known, but may include receptor tyrosine kinases, G
protein coupled receptors or cell adhesion molecules
(CAM).
|
|
The ATP depletion-repletion model of TJ biogenesis may have relevance
to recovery from ischemia reperfusion or hypoxia reoxygenation injuries. Although this model has not been as extensively characterized as the Ca2+ switch, a major
difference appears to be the nature of the interactions of TJ proteins
with the cytoskeleton (Fig. 3). ZO-1 has been proposed to interact with
actin cytoskeleton through spectrin (31), and recent work with the ATP
depletion-repletion model of junction assembly supports this finding
(53). Transepithelial resistance drops rapidly and reversibly in
parallel with declining ATP levels, and ZO-1, ZO-2 and cingulin shift
into a Triton X-100-insoluble pool, consistent with increased
cytoskeletal interaction during ATP depletion. Analysis of
immunoprecipitations from ATP-depleted cells identified ZO-1 and fodrin
(a spectrin analog that links proteins to the cytoskeleton) within a
large molecular weight complex. This is in contrast to the findings
with the Ca2+ switch model; as the
TJ is disassembled in LC, TJ proteins become more
soluble, suggesting that they are less tightly associated with the
actin cytoskeleton (Fig. 3). The differences in interactions between
the cytoskeleton and TJ proteins in these two models suggests that the
mechanisms of TJ assembly are likely to significantly vary depending
upon the cause of junctional disassembly.
The essential role of Ca2+ in the
formation of intracellular junctions is well established. Extracellular
Ca2+ is required for homotypic
interactions of E-cadherin and is likely to be the initial event of
junctional complex formation (26). However, the source of intracellular
Ca2+ that is critical for TJ
biogenesis has important implications for understanding the signaling
mechanisms involved in TJ formation (Fig. 4). Using fura 2-loaded MDCK
cells and continuous spectrofluorometric measurements, it was
demonstrated that there were large increases in intracellular
Ca2+ that were particularly
evident at points of cell-cell contact (37), the site of junction
formation and apical membrane biogenesis. These observations were
extended by chelating intracellular
Ca2+ and demonstrating a marked
attenuation of TER development (52). Furthermore, chelation of
intracellular Ca2+ retarded the
movement of ZO-1 from intracellular sites to the plasma membrane during
the switch. A fraction of ZO-1 was redistributed from the
Triton-soluble to Triton-insoluble pool during the
Ca2+ switch, which could be
inhibited by prior chelation of
Ca2+. Although these studies
demonstrate the importance of intracellular Ca2+, it was only recently that a
role for potentially regulated intracellular Ca2+ stores was demonstrated (51).
Thapsigargin (TG) inhibits endoplasmic reticulum (ER)
Ca2+-adenosinetriphosphatase
(Ca2+-ATPase) and depletes
intracellular ER stores of Ca2+;
this renders the cell insensitive to further stimulation of ER
Ca2+ release. Selective depletion
of calcium stores prior to initiation of cell-cell contact disrupts the
biogenesis of desmosomes and TJs without obviously affecting cell-cell
contact or E-cadherin (51). The sorting of ZO-1 and the desmosomal
protein desmoplakin I are disturbed in TG-treated cells despite the
presence of a normal intracellular
Ca2+ concentration. The dependence
of TJ formation on intracellular Ca2+ stores is consistent with a
role for classic signaling pathways that utilize heterotrimeric G
proteins and PKC (schematized in Fig. 4). Although the sorting of TJ
proteins appears to be dependent upon intact internal
Ca2+ stores and PKC, PKC does not
appear to be required for biochemical stabilization of ZO-1 into the
cytoskeletal fraction. Internal Ca2+ stores are required for
maintaining ZO-1 in the TJ, but TG and PKC inhibitors have minimal
effects on already established tight monolayers. These findings
emphasize that different mechanisms are required for the maintenance
and assembly of TJs.
As mentioned above, the assembly of TJs appears to be regulated, in
part, by protein phosphorylation events. Over the past several years a
variety of nonspecific and specific PKC agonists and antagonists have
been used to elucidate some of the mechanisms relevant to TJ formation.
The PKC inhibitor 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7)
markedly inhibits the development of transepithelial resistance of MDCK
cells after switching from LC to NC media and inhibits the sorting of ZO-1 and cingulin from an intracellular site to the
lateral membrane (36). Immunoprecipitates of ZO-1/ZO-2 complex in cells
labeled with
[32P]orthophosphate
identify unknown phosphorylated proteins at 130 kDa (6, 50) as well as
330 and 65 kDa (50). This complex can be detected in cells cultured in
LC or NC, suggesting they exist as a preformed complex.
Consistent with the effect of protein kinase inhibitors on TER and ZO-1
translocation, the PKC agonist 1,2-dioctanoylglycerol
(DiC8; Ref. 6) has the opposite
effect. DiC8 stimulates translocation of ZO-1 from the
cytoplasm to the membrane and promotes actin cytoskeletal
reorganization. Treatment of cells with PKC agonists also increases the
number of TJ fibrils and is associated with decreased paracellular flux
of [3H]mannitol,
although there was only a small increase in transepithelial resistance.
As predicted from the studies with PKC agonists, the PKC inhibitor
calphostin blocks development of TER in the
Ca2+ switch and prevents
translocation of ZO-1 to the membrane (50). PKC activity increases
shortly after switching to NC and there is a significant increase in
total PKC activity of the membrane fraction. By immunofluorescence,
PKC-
translocates to the lateral membrane colocalizing with ZO-1
(50), and others have also found PKC-
in the TJ of epithelial cells
(19). However, there was no change in extractability of ZO-1 in the
presence of calphostin C, suggesting that PKC is not required for
cytoskeletal association, even though intracellular
Ca2+ is clearly required (52).
PKC-
may also regulate TJ assembly as cells expressing dominant
negative mutants were resistant to 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced increases
in paracellular flux and TER (43). Several studies have shown that ZO-1
can be directly phosphorylated (30, 50), but the implications for TJ
maintenance and biogenesis are unknown. Although the kinase(s) responsible for phosphorylating ZO-1 have not been identified, a serine
protein kinase has been partially characterized that selectively
interacts with the SH3 domain of ZO-1 and is associated with the
junctional complexes extracted from MDCK cells (4).
Activation of PKC pathways appears to be downstream of
E-cadherin-mediated events. There is no obvious effect of the PKC
agonist (DiC8) on the cellular
distribution of E-cadherin, and stimulation of PKC with the agonist
overcomes the block on ZO-1 translocation from cytosol to membrane that
is seen with anti-E-cadherin antibodies. Nevertheless, this does not
exclude more subtle regulation of the adherens junction by PKC.
Catenins link E-cadherin to the actin cytoskeleton and are required for
the normal epithelial cell phenotype. The
-,
-, and
-catenins
associate with ZO-1 in LC and 2 h after
Ca2+ switch, but these
associations were not detected in confluent monolayers (40). The
-catenin appears to be important for the translocation of ZO-1 from
the cytosol to the TJ. In invasive colon carcinoma cell lines lacking
-catenin, treatment with a PKC activator (TPA) causes restoration of
a normal phenotype by stimulating desmosomal and TJ proteins without
inducing
-catenin expression or affecting E-cadherin (56). Studies
with both agonists and antagonists of PKC are consistent with a central
role for PKC in TJ biogenesis. Taken together, these results highlight the importance of phosphorylation events, in part through PKC, in TJ
formation. Although less clear, some evidence suggests that PKC may
also have role in maintaining TJs. A protein kinase inhibitor can
prevent disassembly of TJs induced by low extracellular
Ca2+ (12), but treatment of
confluent monolayers with a PKC inhibitor in NC had no effect on TER or
ZO-1 staining (50). In other cell types, such as thyroid follicular
cells, different kinases or alternate mechanisms may be important.
Stimulation of cAMP/PKA promotes barrier function of thyroid cells
probably via stabilization of
Ca2+-dependent cell adhesion (38).
It is likely that other protein kinases (PKA) also participate in the
maintenance and assembly of TJs.
Since PKC is critical for mobilizing intracellular
Ca2+ during TJ biogenesis, it is
quite likely that heterotrimeric G proteins are involved in this
process as well. Evidence from several sources support an important
role for G proteins in TJ biogenesis. Several G
subunits including
G
i-2,
G
12, and
G
o have been localized in the
vicinity of the TJ (17-19, 27), and
G
s may present in this region as well (Denker, unpublished observations). The specific G
proteins involved in this process have not been identified. Studies in
MDCK cells using the Ca2+ switch
model of TJ biogenesis demonstrate a variety of effects when cells are
treated activators [AlF3 or
guanosine 5'-O-(3-thiotriphosphate)] and
inactivators (pertussis toxin) of some G protein families (5). In these
studies, direct stimulation of adenylyl cyclase with forskolin or the
use of cAMP analogs significantly reduced TER development in the
Ca2+ switch. Direct activation of
G
s with cholera toxin should
also lead to increased cAMP levels and result in lower TER, but cholera toxin caused only a small reduction in TER development (5). Another
line of evidence implicating G
subunits in TJ formation comes from
Ca2+ switch experiments on MDCK
cell lines stably transfected with G
subunits.
G
o (pertussis toxin family
member 69% identical to
G
i-2) expressed in MDCK cells
is localized to the TJ and can be immunoprecipitated with ZO-1 (18).
Stably expressed G
o or a
constitutively activated mutant (impaired GTPase activity) of G
o (Q205L) had no effect on TER
in confluent monolayers. However, during the
Ca2+ switch, activated
G
o (Q205L) MDCK cells achieved
significantly higher peak TER values and accelerated the rate of TJ
biogenesis (18). The complexity of signaling pathways and
the multitude of G proteins within a cell make it difficult to clearly
establish the relevant G
subunits and their role in TJ biogenesis.
Nevertheless, these findings are consistent with the concept of
multiple G
subunits affecting TJ biogenesis. Furthermore, treatment
of confluent monolayers with AlF3
also affected TER (5) suggesting that G proteins may also participate
in the steady-state regulation of TJ integrity and paracellular
permeability.
The complexity of the TJ in regulating the paracellular pathway and
providing the fence that separates apical and basolateral membrane
domains is now apparent. Although there has been significant progress
in the last few years toward identifying the components of the TJ, our
understanding of assembly and maintenance of this structure remains far
from complete. In many cell types this is a highly dynamic structure
important to many critical cellular functions. In this regard, it is
not surprising that the TJ is composed of a complex array of regulated
proteins that are in place to ensure its integrity, allow regulation,
and permit reestablishment under a variety of biological circumstances.
Of particular interest in the future will be understanding the
signaling mechanisms underlying reassembly of the TJ after ischemic and
other insults. This will provide the basic understanding that may then
make it possible to intervene therapeutically with agents that modulate
these signaling pathways in circumstances like acute renal failure and
intestinal ischemia.
 |
ACKNOWLEDGEMENTS |
S. K. Nigam and B. M. Denker are funded by the National Institutes
of Health. S. K. Nigam is an Established Investigator of the American
Heart Association.
 |
FOOTNOTES |
Address for reprint requests: B. M. Denker, Harvard Institute of
Medicine, 77 Ave. Louis Pasteur, Boston, MA 02115.
 |
REFERENCES |
1.
Anderson, J. M.
Cell signalling: MAGUK magic.
Curr. Biol.
6:
382-384,
1996[Medline].
2.
Anderson, J. M.,
and
C. M. Van Itallie.
Tight junctions and the molecular basis for regulation of paracellular permeability.
Am. J. Physiol.
269 (Gastrointest. Liver Physiol. 32):
G467-G475,
1995[Abstract/Free Full Text].
3.
Ando-Akatsuka, Y.,
M. Saitou,
T. Hirase,
M. Kishi,
A. Sakakibara,
M. Itoh,
S. Yonemura,
M. Furuse,
and
S. Tsukita.
Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues.
J. Cell Biol.
133:
43-7,
1996[Abstract/Free Full Text].
4.
Balda, M. S.,
J. M. Anderson,
and
K. Matter.
The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain.
FEBS Lett.
399:
326-332,
1996[Medline].
5.
Balda, M. S.,
L. Gonzalez-Mariscal,
M. Macias-Silva,
M. E. Torres-Marquez,
J. A. Garcia Sainz,
and
M. Cereijido.
Assembly and sealing of tight junctions: possible participation of G- proteins, phospholipase C, protein kinase C and calmodulin.
J. Membr. Biol.
122:
193-202,
1991[Medline].
6.
Balda, M. S.,
L. Gonzalez-Mariscal,
K. Matter,
M. Cereijido,
and
J. M. Anderson.
Assembly of the tight junction: the role of diacylglycerol.
J. Cell Biol.
123:
293-302,
1993[Abstract/Free Full Text].
7.
Balda, M. S.,
J. A. Whitney,
C. Flores,
S. González,
M. Cereijido,
and
K. Matter.
Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction protein.
J. Cell Biol.
134:
1031-1049,
1996[Abstract/Free Full Text].
8.
Beatch, M.,
L. A. Jesaitis,
W. J. Gallin,
D. A. Goodenough,
and
B. R. Stevenson.
The tight junction protein ZO-2 contains three PDZ (PSD-95/Discs-Large/ZO-1) domains and an alternatively spliced region.
J. Biol. Chem.
271:
25723-25726,
1996[Abstract/Free Full Text].
9.
Cereijido, M.,
L. González-Mariscal,
and
G. Contreras.
Tight junction barrier between organisms and environment.
News Physiol. Sci.
4:
72-74,
1989.[Abstract/Free Full Text]
10.
Cereijido, M.,
L. Gonzalez-Mariscal,
R. G. Conreras,
J. M. Gallardo,
R. Garcia-Villegas,
and
J. Valdes.
The making of a tight junction.
J. Cell Sci. Suppl.
17:
127-132,
1993.
11.
Citi, S.
The molecular organization of tight junctions.
J. Cell Biol.
121:
485-489,
1993[Free Full Text].
12.
Citi, S.
Protein kinase inhibitors prevent dissociation induced by low extracellular calcium in MDCK epithelial cells.
J. Cell Biol.
117:
169-178,
1992[Abstract/Free Full Text].
13.
Citi, S.,
and
N. Denisenko.
Phosphorylation of the tight junction protein cingulin and the effects of protein kinase inhibitors and activators in MDCK epithelial cells.
J. Cell Sci.
108:
2917-26,
1995[Abstract].
14.
Citi, S.,
H. Sabanay,
R. Jakes,
B. Geiger,
and
J. Kendrick-Jones.
Cingulin, a new peripheral component of tight junctions.
Nature
333:
272-6,
1988[Medline].
15.
Citi, S.,
H. Sabanay,
J. Kendrick-Jones,
and
B. Geiger.
Cingulin: characterization and localization.
J. Cell Sci.
93:
107-22,
1989[Abstract/Free Full Text].
16.
Claude, P.
Morphologic factors influencing transepithelial permeability: a model for the resistance of the zona occludens.
J. Membr. Biol.
39:
219-232,
1979.
17.
de Almeida, J. B.,
E. J. Holtzman,
P. Peters,
L. Ercolani,
D. A. Ausiello,
and
J. L. Stow.
Targeting of chimeric G
i proteins to specific membrane domains.
J. Cell Sci.
107:
507-515,
1994[Abstract].
18.
Denker, B. M.,
C. Saha,
S. Khawaja,
and
S. K. Nigam.
Involvement of a heterotrimeric G protein
subunit in tight junction biogenesis.
J. Biol. Chem.
271:
25750-25753,
1996[Abstract/Free Full Text].
19.
Dodane, V.,
and
B. Kachar.
Identification of isoforms of G proteins and PKC that colocalize with tight junctions.
J. Membr. Biol.
149:
199-209,
1996[Medline].
20.
Furuse, M.,
K. Fujimoto,
N. Sato,
T. Hirase,
S. Tsukita,
and
S. Tsukita.
Overexpression of occludin, a tight junction-associated integral membrane protein, induces the formation of intracellular multilamellar bodies bearing tight junction-like structures.
J. Cell Sci.
109:
429-35,
1996[Abstract].
21.
Furuse, M.,
T. Hirase,
M. Itoh,
A. Nagafuchi,
S. Yonemura,
S. Tsukita,
and
S. Tsukita.
Occludin: a novel integral membrane protein localizing at tight junctions.
J. Cell Biol.
123:
1777-88,
1993[Abstract/Free Full Text].
22.
Furuse, M.,
M. Itoh,
T. Hirase,
A. Nagafuchi,
S. Yonemura,
S. Tsukita,
and
S. Tsukita.
Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions.
J. Cell Biol.
127:
1617-26,
1994[Abstract/Free Full Text].
23.
Garrod, D.,
M. Chidgey,
and
A. North.
Desmosomes: differentiation, development, dynamics and disease.
Curr. Opin. Cell Biol.
8:
670-8,
1996[Medline].
24.
Gottardi, C. J.,
M. Arpin,
A. S. Fanning,
and
D. Louvard.
The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts.
Proc. Natl. Acad. Sci. USA
93:
10779-84,
1996[Abstract/Free Full Text].
25.
Gumbiner, B.,
T. Lowenkopf,
and
D. Apatira.
Identification of 160-kDa polypeptide that binds to the tight junction protein ZO-1.
Proc. Natl. Acad. Sci. USA
88:
3460-3434,
1991[Abstract/Free Full Text].
26.
Gumbiner, B. M.
Cell adhesion: the molecular basis of tissue architecture and morphogenesis.
Cell
84:
345-57,
1996[Medline].
27.
Hamilton, S. E.,
and
N. M. Nathanson.
Differential localization of G proteins, G
o and G
i1, -2, and -3 in polarized epithelial MDCK Cells.
Biochem. Biophys. Res. Commun.
234:
1-7,
1997[Medline].
28.
Hanks, S. K.,
and
T. R. Polte.
Signaling through focal adhesion kinase.
Bioessays
19:
137-145,
1997[Medline].
29.
Hirokawa, N.,
and
L. G. Tilney.
Interactions between actin filaments and between actin filaments and membranes in quick frozen and deeply etched hair cells of the chick ear.
J. Cell Biol.
95:
249-261,
1982[Abstract/Free Full Text].
30.
Howarth, A. G.,
K. L. Singer,
and
B. R. Stevenson.
Analysis of the distribution and phosphorylation state of ZO-1 in MDCK and nonepithelial cells.
J. Membr. Biol.
137:
261-270,
1994[Medline].
31.
Itoh, M.,
A. Nagafuchi,
S. Yonemura,
T. Kitani-Yasuda,
S. Tsukita,
and
S. Tsukita.
The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction associated protein in epithelial cells: cDNA cloning and immunolocalization.
J. Cell Biol.
124:
491-502,
1993[Abstract/Free Full Text].
32.
Keon, B. H.,
S. Schafer,
C. Kuhn,
C. Grund,
and
W. W. Franke.
Symplekin, a novel type of tight junction plaque protein.
J. Cell Biol.
134:
1003-1018,
1996[Abstract/Free Full Text].
33.
Kumar, N. M.,
and
N. B. Gilula.
The gap junction communication channel.
Cell
84:
381-388,
1996[Medline].
34.
Lambie, E. J.
Cell-cell communication: receptor function at the junction.
Curr. Biol.
6:
1089-1091,
1996[Medline].
35.
McCarthy, K. M.,
I. B. Skare,
M. C. Stankewich,
M. Furuse,
S. Tsukita,
R. A. Rogers,
R. D. Lynch,
and
E. E. Schneeberger.
Occludin is a functional component of the tight junction.
J. Cell Sci.
109:
2287-98,
1996[Abstract].
36.
Nigam, S. K.,
N. Denisenko,
E. Rodriguez-Boulan,
and
S. Citi.
The role of phosphorylation in development of tight junctions in cultured renal epithelial (MDCK) cells.
Biochem. Biophys. Res. Commun.
181:
548-553,
1991[Medline].
37.
Nigam, S. K.,
E. Rodriguez-Boulan,
and
R. B. Silver.
Changes in intracellular calcium during the development of epithelial polarity and junctions.
Proc. Natl. Acad. Sci. USA
89:
6162-6166,
1992[Abstract/Free Full Text].
38.
Nilsson, M.,
H. Fagman,
and
L. E. Ericson.
Ca2+-dependent and Ca2+-independent regulation of the thyroid epithelial junction complex by protein kinases.
Exp. Cell Res.
225:
1-11,
1996[Medline].
39.
Nusrat, A.,
M. Giry,
J. R. Turner,
S. P. Colgan,
C. A. Parkos,
D. Carnes,
E. Lemichez,
P. Boquet,
and
J. L. Madara.
Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia.
Proc. Natl. Acad. Sci. USA
92:
10629-10633,
1995[Abstract/Free Full Text].
40.
Rajasekaran, A. K.,
M. Hojo,
T. Huima,
and
E. Rodriguez-Boulan.
Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions.
J. Cell Biol.
132:
451-463,
1996[Abstract/Free Full Text].
41.
Reynolds, A. B.,
J. Daniel,
P. D. McCrea,
M. J. Wheelock,
J. Wu,
and
Z. Zhang.
Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes.
Mol. Cell. Biol.
14:
8333-8342,
1994[Abstract/Free Full Text].
42.
Rodewald, R. S.,
S. B. Newman,
and
M. J. Karnovsky.
Contraction of isolated brush borders from the intestinal epithelium.
J. Cell Biol.
70:
541-554,
1976[Abstract/Free Full Text].
43.
Rosson, D.,
T. G. O'Brien,
J. A. Kampherstein,
Z. Szallasi,
K. Bogi,
P. M. Blumberg,
and
J. M. Mullin.
Protein kinase C-
activity modulates transepithelial permeability and cell junctions in the LLC-PK1 epithelial cell line.
J. Biol. Chem.
272:
14950-14953,
1997[Abstract/Free Full Text].
44.
Sakakibara, A.,
M. Furuse,
M. Saito,
Y. Ando-Akatsuka,
and
S. Tsukita.
Possible involvement of phosphorylation of occludin in tight junction formation.
J. Cell Biol.
137:
1393-1401,
1997[Abstract/Free Full Text].
45.
Satoh, H.,
Y. Zhong,
H. Isomura,
M. Saitoh,
K. Enomoto,
N. Sawada,
and
M. Mori.
Localization of 7H6 tight junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells.
Exp. Cell Res.
222:
269-74,
1996[Medline].
46.
Songyang, Z.,
A. S. Fanning,
C. Fu,
J. Xu,
S. M. Marfatia,
A. H. Chishti,
A. Crompton,
A. C. Chan,
J. M. Anderson,
and
L. C. Cantley.
Recognition of unique carboxyl-terminal motifs by distinct PDZ domains.
Science
275:
73-77,
1997[Abstract/Free Full Text].
47.
Stevenson, B. R.,
and
D. A. Begg.
Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells.
J. Cell Sci.
107:
367-75,
1994[Abstract].
48.
Stevenson, B. R.,
and
D. A. Goodenough.
Zonulae occludentes in junctional complex-enriched fractions from mouse liver: preliminary morphological and biochemical characterization.
J. Cell Biol.
98:
1209-1221,
1984[Abstract/Free Full Text].
49.
Stevenson, B. R.,
J. D. Silicano,
M. S. Mooseker,
and
D. A. Goodenough.
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zona occluden) in a variety of epithelia.
J. Cell Biol.
103:
755-766,
1986[Abstract/Free Full Text].
50.
Stuart, R. O.,
and
S. K. Nigam.
Regulated assembly of tight junctions by protein kinase C.
Proc. Natl. Acad. Sci. USA
92:
6072-6076,
1995[Abstract/Free Full Text].
51.
Stuart, R. O., A. Sun, K. T. Bush, and
S. K. Nigam. Dependence of epithelial intercellular
junction biogenesis on thapsigargin-sensitive intracellular calcium
stores. J. Biol. Chem. 271: 1996.
52.
Stuart, R. O.,
A. Sun,
M. Panichas,
S. C. Hebert,
B. M. Brenner,
and
S. K. Nigam.
Critical role for intracellular calcium in tight junction biogenesis.
J. Cell. Physiol.
159:
423-433,
1994[Medline].
53.
Tsukamoto, T.,
and
S. K. Nigam.
Tight Junction proteins form large complexes and associate with the cytoskeleton in an ATP depletion model for reversible junction assembly.
J. Biol. Chem.
272:
16133-16139,
1997[Abstract/Free Full Text].
54.
Tsukita, S.,
K. Oishi,
T. Akiyama,
Y. Yamanashi,
T. Yamamoto,
and
S. Tsukita.
Specific proto-oncogenic tyrosine kinase of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated.
J. Cell Biol.
113:
867-879,
1991[Abstract/Free Full Text].
55.
Tsuneo, K.,
U. Brauneis,
Z. Gatmaitan,
and
I. Arias.
Extracellular ATP, intracellular calcium and canalicular contraction in rat hepatocyte doublets.
Hepatology
14:
640-647,
1991[Medline].
56.
van Hengel, J.,
L. Gohon,
E. Bruyneel,
S. Vermeulen,
M. Cornelissen,
M. Mareel,
and
F. van Roy.
Protein kinase C activation upregulates intercellular adhesion of
-catenin-negative human colon cancer cell variants via induction of desmosomes.
J. Cell Biol.
137:
1103-1116,
1997[Abstract/Free Full Text].
57.
Weber, E.,
G. Berta,
A. Tousson,
P. St. John,
M. W. Green,
U. Gopalokrishnan,
T. Jilling,
E. J. Sorscher,
T. S. Elton,
D. R. Abrahamson,
and
K. L. Kirk.
Expression and polarized targeting of a rab3 isoform in epithelial cells.
J. Cell Biol.
125:
583-94,
1994[Abstract/Free Full Text].
58.
Wong, V.,
and
B. M. Gumbiner.
A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier.
J. Cell Biol.
136:
399-409,
1997[Abstract/Free Full Text].
59.
Yamada, K. M.,
and
B. Geiger.
Molecular interactions in cell adhesion complexes.
Curr. Opin. Cell Biol.
9:
76-85,
1997[Medline].
60.
Zahraoui, A.,
G. Joberty,
M. Arpin,
J. J. Fontaine,
R. Hellio,
A. Tavitian,
and
D. Louvard.
A small rab GTPase is distributed in cytoplasmic vesicles in non polarized cells but colocalizes with the tight junction marker ZO-1 in polarized epithelial cells.
J. Cell Biol.
124:
101-15,
1994[Abstract/Free Full Text].
61.
Zhong, Y.,
K. Enomoto,
H. Tobioka,
Y. Konishi,
M. Satoh,
and
M. Mori.
Sequential decrease in tight junctions as revealed by 7H6 tight junction-associated protein during rat hepatocarcinogenesis.
Jpn. J. Cancer Res.
85:
351-6,
1994[Medline].
62.
Zhong, Y.,
T. Saitoh,
T. Minase,
N. Sawada,
K. Enomoto,
and
M. Mori.
Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2.
J. Cell Biol.
120:
477-83,
1993[Abstract/Free Full Text].
AJP Renal Physiol 274(1):F1-F9
0363-6127/98 $5.00
Copyright © 1998 the American Physiological Society